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Abstract 
The group of prostaglandin (PG) E 2- and prostacyclin receptors consists of different subtypes, which exibit different affinities for 
prostaglandins and synthetic analogues. PGE 2 activates the E-type PG receptor subtypes EP1, EP 2 and EP3, whereas the PGE 2 analogue, 
sulprostone, binds only to the EP 1 and EP 3 receptor subtypes. The stable PGI 2 analogues, iloprost and cicaprost, both activate the PGI 2 
receptor (IP) and iloprost, additionally, bind to the EP 1 subtype. Using these subtype-selective PG receptor agonists, we studied the 
interaction of PG receptor subtypes with G s and Gi-type heterotrimeric guanine nucleotide-binding proteins (G proteins) in membranes 
from the human erythroleukaemia cell line, HEL. Sulprostone stimulated high-affinity GTPase in HEL membranes in a pertussis toxin 
(PTX)-sensitive manner. In contrast, the stimulations induced by PGE 2, iloprost and cicaprost were only partially inhibited by PTX. 
PGE 2, sulprostone, iloprost and cicaprost stimulated cholera toxin-catalysed ADP-ribosylation as well as labelling with GTP azidoanilide 
of membrane proteins comigrating with immunologically identified G i protein a subunits. Furthermore, PGE2, iloprost and cicaprost 
enhanced GTP azidoanilide-labelling of G s protein o~ subunits, whereas ulprostone did not. We suggest that in HEL cells (1) EP 1 and 
EP 3 receptor subtypes activate G i proteins, that (2) the EP 2 receptor subtype activates G s proteins and that (3) the IP receptor activates 
both G i and Gs proteins. 
Keywords: Prostaglandin; G protein; Signal transduction 
1. Introduction 
Prostaglandins (PGs) are involved in various processes 
such as inflammation, relaxation and contraction of smooth 
muscles and activation and inhibition of platelet function 
[1]. The diverse biological activities of PGs are mediated 
by specific receptors, which are characterized pharmaco- 
Abbreviations: [Ca 2+ ]i, cytosolic Ca z+ concentration; CTX, cholera 
toxin; EP1, EP2, EP3, receptor subtypes, which bind E-type prosta- 
glandins; G proteins, heterotrimefic guanine nucleotide-binding proteins; 
G i and Gs, inhibitory and stimulatory G proteins; HEL, human ery- 
throleukaemia cell line; IP, prostaglandin 12 receptor; PG, prostaglandin; 
PGE2, prostaglandin E2; PTX, pertussis toxin; prostanoid receptors des- 
ignated following the recommendation of the IUPHAR Commission on 
Receptor Nomenclature and Classification. 
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logically by selective agonists and antagonists [2,3]. Three 
subtypes of PGE receptors (EP receptors EP1, EP/ and 
EP 3) are known, and recently, the cloning of the EP 
receptors has been reported including several different 
splice variants of the EP 3 receptor subtype [4-15]. PGE 2 
has agonistic activity at all of the receptor subtypes and 
displays identical binding properties at all EP 3 receptor 
isoforms [3,11-15]. Up to now, no subtypes or isoforms 
are known for the also cloned EP 1, EP 2 and PGI 2 (IP) 
receptors [4-8,16,17]. The protein sequences deduced from 
the cDNAs of the cloned prostanoid receptors as well as 
expression studies with the cloned receptors upport the 
view that prostanoids exerting their effects through recep- 
tors belonging to the heterotrimeric guanine nucleotide-bi- 
nding protein (G protein)-coupled receptor superfamily 
[4-21]. To date, however, direct evidence for prostanoid- 
induced G protein activation have only been presented for 
the EP3~, EP3~ and EPac receptor isoforms by receptor 
expression and G protein reconstitution and for thrombox- 
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ane A 2 receptors by stimulated incorporation of a radioac- 
tive-labelled GTP analogue into G protein a subunits 
[10,22,23]. 
We showed recently that in HEL cells, PGE 2 and its 
stable analogue, sulprostone, increase cytosolic Ca 2+ con- 
centration ([Ca2+] i) in a pertussis toxin (PTX)-sensitive 
manner, suggesting signal transduction by G i proteins [24]. 
The stable PGI2-analogues, iloprost and cicaprost, lead to 
increases in [Ca2+] i in a FTX-insensitive manner. The 
purpose of the present study was to characterize G protein 
activation via EP and IP receptors, and in particular, to 
study the interaction of EP and IP receptors with G 
proteins of the G~ and G s family in HEL membranes. We 
report here that PGE 2, iloprost and cicaprost activate both 
G i and G s, whereas ulprostone activates only G i proteins. 
Based on the known receptor binding characteristics of the 
PGs employed, we conclude that in HEL cells EP 1 and EP 3 
receptor subtypes couple to G~ proteins and that the EP 2 
receptor subtype couples to G S proteins. The IP receptor 
activates both G i and G s prol:eins. 
2. Materials and methods 
2.1. Reagents 
Sulprostone, cicaprost and iloprost were kind gifts from 
Drs. E. Schillinger and K.H. Thierauch (Schering, Berlin, 
Germany). PGE 2, PGD 2 and PGF2~, PTX and cholera- 
toxin (CTX) were obtained from Sigma (Deisenhofen, 
Germany). [32p]NAD (800 Ci/mM) was from Dupont/ 
New England Nuclear (Bad Homburg, Germany). Sources 
of other materials have been described elsewhere [24-28]. 
2.2. Cell culture 
HEL cells were cultured exactly as described in [24]. In 
some experiments, PTX (100 ng/ml) or its carrier (con- 
trol) were added to the culture medium, and the cells were 
incubated for an additional 2',4 h. Under these conditions, 
the toxin virtually completely ADP-ribosylated Gi protein 
a subunits as assessed by subsequent PTX-catalysed 
ADP-ribosylation i  membranes using [32p]NAD (data not 
shown). 
2.3. Measurement of GTPase activity 
HEL membranes were prepared as described [26]. GTP 
hydrolysis was determined according to [28] with modifi- 
cations. Briefly, 50 /.tl of assay mixture contained 5.5-7.5 
/xg of HEL membrane protein, 0.5 mM MgCI 2, 0.1 mM 
EGTA, 0.1 mM ATP, 1 mM adenosine 5'-[ fl,~--imido]tri- 
phosphate, 5 mM creatine phosphate, 40 /xg creatine ki- 
nase, 1 mM dithiothreitol, 0.2% (w/v)  bovine serum 
albumin in 50 mM triethanolamine/HCl (pH 7.4), and 0.5 
/zM [~--32p]GTP (0.1 /zCi/assay tube). Assay mixtures 
contained thrombin or PGs at various concentrations and 
were preincubated for 3 min at 25°C. Reactions were 
started by the addition of HEL membranes and were 
incubated for 15 min. Low-affinity GTPase activity was 
determined in the presence of 50 /xM GTP and amounted 
to < 10% of total GTPase activity. 
2.4. Agonist-stimulated CTX-catalysed ADP-ribosylation 
of membrane proteins 
HEL cells (107 cells/assay tube, resulting in 28-52/zg 
of membrane protein/assay tube) were homogenized by 
20 passes through a 26 gauge needle in a homogenization 
buffer consisting of 150 mM NaC1, 3 mM MgC12, 1 mM 
EGTA, 1 mM dithiothreitol and 20 mM Hepes/NaOH (pH 
7.4). After centrifugation at 1000 X g for 10 min at 4°C, 
the pellet was discarded and the supernatant suspension 
was incubated for 60 min at 30°C in the above buffer 
supplemented with 1 mM guanosine 5'-[ fl,r-imido]triphos- 
phate. Thereafter, the suspension was centrifuged at 30 000 
× g for 15 min at 4°C. The pellet, referred to as mem- 
branes, was dissolved in a buffer consisting of 1 mM 
EDTA and 10 mM Tris-HCl (pH 7.4). CTX was activated 
by incubation for 10 min at 30°C in 20 mM dithiothreitol. 
Fifty /zl of assay mixture contained 3 mM MgC12, 1 mM 
ATP, 10 mM thymidine, 0.2% (w/v)  bovine serum albu- 
min, 100 mM potassium phosphate (pH 7.4), 2 /zg of 
activated CTX and 3 /xM [32p]NAD (5 /xCi/assay tube). 
Assays were performed in the presence or absence of 1 
U/ml  thrombin or 10/xM of PGs. After preincubation for 
3 min at 25°C, reactions were started by the addition of 
HEL membranes. After incubation for 60 min at 30°C, 
reactions were terminated by the addition of ice-cold 20 
mM Hepes/NaOH (pH 7.4), and centrifugation for 10 min 
at 12000 X g at 4°C. The pellets were dissolved in a 
buffer according to Laemmli [29]. 
2.5. [ol- 32p]GTP azidoanilide-labelling of membrane pro- 
teins 
In a final assay volume of 60 ~1, HEL membranes (50 
~g of protein/assay tube) were preincubated for 3 min in 
a buffer consisting of 0.1 mM EDTA, 5 mM MgC12, 1 
mM benzamidine, 10 mM NaCI, 10/~M GDP and 30 mM 
Hepes/NaOH (pH 7.4), in the presence or absence of 1 
U/ml  thrombin or 10 ~M of PG. After addition of 
[a-32p]GTP azidoanilide (1.5 /xCi/assay tube, 15 nM 
final concentration), the assay mixtures were incubated for 
the time indicated in the figure legends. Stopping and 
irradiation of samples were performed as described [27]. 
2.6. SDS-PAGE, immunoblotting, and antisera 
After SDS-PAGE and blotting of the proteins onto 
nitrocellulose filters, the filters were autoradiographed as 
described [25]. Immunoblotting was performed by incuba- 
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tion of the filters with antisera generated against synthetic 
peptides corresponding to confined regions of G protein a 
subunits. The ot . . . . . .  -peptide antiserum, AS 8, strongly 
recognizes the ot subunits of Gil_3, Go1+2, G s and G t. 
Affinity-purified aicommon-peptide antibody, AS 266, 
specifically recognizes o~il_ 3 subunits, whereas the anti- 
bodies AS 190 and AS 269 detecting exclusively O~il and 
ai2 subunits, respectively [30]. The a~ peptide antiserum, 
AS 348, was raised against the specific C-terminal a s 
subunit peptide sequence RMHLRQYELL (one letter code) 
and reacts specifically with a~ subunits of G proteins. 
2.7. M isce l laneous  
Protein was determined according to Ref. [31]. [~'- 
32 P]GTP was prepared as described [32]. [a-32 P]GTP azi- 
doanilide was prepared according to Ref. [27]. 
3. Results 
In order to study the role of G proteins in PG-induced 
signal transduction, we assessed high-affinity GTP hydrol- 
ysis in HEL membranes in the presence and absence of 
receptor agonists. Thrombin, a very effective receptor ago- 
nist leading to a rise in [Ca 2+ ]i in HEL cells was used as a 
standard stimulus in all experiments [24]. Maximal stimu- 
latory effects on high-affinity GTPase were observed at 1 
U /ml  of thrombin and 10/zM each of PGE 2, sulprostone, 
iloprost and cicaprost (data not shown). 
Thrombin increased GTPase activity by about 60% over 
basal level (Table 1). PTX treatment abolished its stimula- 
tory effect. Iloprost and cicaprost increased GTP hydroly- 
sis by about 50% and 25%, respectively, and PTX partially 
inhibited these increases. The stimulatory effect induced 
by iloprost was reduced by about 75%, and the one 
induced by cicaprost was reduced by about 50%. PGE 2 
stimulated GTP hydrolysis by about 35% and its analogue, 
sulprostone, increased GTPase activity by about 25%. The 
Table 1 
Effects of thrombin and E- and I-type PGs on high-affinity GTPase 
activity in HEL membranes; percentage increase 
Agonist Cell treatment 
Control PTX 
Thrombin 58.8 _+ 3.4 0.5 + 2.8 
PGE 2 37.1 + 1.3 19.7+ 1.0 
Sulprostone 23.2 + 1.2 3.4 + 0.7 
lloprost 48.9 + 3.4 12.1 + 1.9 
Cicaprost 26.5 + 3.4 13.2 + 1.2 
Treatment ofcells with PTX or its carder (control) and determination f 
basal and stimulated GTPase activities were performed as described in
Section 2. The concentration of thrombin was 1 U/ml and of the PGs 10 
~M each. The results hown are the means+ S.D. of five independent 
experiments with assay quadruplicates, performed with different mem- 
brane preparations. 
V ~  
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Fig. 1. Identification f G protein o~ subunits after iloprost-stimulated 
crX-catalysed ADP-ribosylation f HEL membrane proteins. CTX-cata- 
lysed ADP-ribosylation was performed as described in Section 2 in the 
presence of 10 ~M iloprost. Thereafter, proteins were separated by 
SDS-PAGE (running separating gels containing 10% (w/v) acrylamide) 
and transferred onto a nitrocellulose filter. The filter was subjected to
autoradiography, t en cut into stripes and incubated with various antisera 
and affinity-purified antibodies. Filter-bound antibodies were visualized 
by a color reaction. A, autoradiogram of membrane proteins. Lane 1, 
a~mmon-peptide antiserum (AS 8). Lane 2, Oqcommon-peptide antibody 
(AS 266). Lane 3, ai2-peptide antibody (AS 269). Lane 4, as-peptide 
antiserum (AS 348). Lane 5, concomitant i cubation with a~-antiserum 
peptide (AS 348) and the synthetic peptide, against which the antiserum 
was raised. Dilutions were: AS 8, 1:300; AS 266, 1:12,5; AS 269 and AS 
348, 1:150. Numbers on the left indicate molecular masses of marker 
proteins (kDa). Results hown are representative for three independent 
experiments. 
increase induced by sulprostone was almost completely 
inhibited by PTX, whereas PGE2-stimulated GTP hydroly- 
sis was reduced by about 50%. This indicates that throm- 
bin and sulprostone activate PTX-sensitive G proteins 
whereas iloprost, cicaprost and PGE 2 activate PTX-sensi- 
tive and -insensitive G proteins in HEL cell membranes. 
To identify G protein oz subunits which had been 
ADP-ribosylated by CTX, immunoblotting was performed 
with specific antisera and antibodies directed against con- 
fined regions of G protein ot subunits. The acommon-peptide 
antiserum, AS 8, detected a broad band of immunoreactive 
proteins with apparent molecular masses of 40/41 kDa 
(Fig. 1, lane 1). The Oqcommon-peptide antibody, AS 266, 
reacted with a 40 kDa and a 41 kDa protein (Fig. 1, lane 
2), and the ai2-peptide antibody, AS 269, recognized a 40 
kDa protein (Fig. 1, lane 3). Unlike to Williams et al. [33], 
who detected o~ subunits of Gil proteins in HEL cells at a 
very low abundance, we could not detect 40//41 kDa 
proteins using the oql-peptide antibody, AS 190 (data not 
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Fig. 2. Effects of thrombin and E- and I-type PG on CTX-catalysed 
ADP-ribosylation f G protein ot subunits in HEL membranes. CTX- 
catalysed ADP-ribosylation was pertbrmed asdescribed in Section 2 in 
the presence orabsence ofstimuli. From seven independent experiments, 
a representative autoradiogram of an SDS gel containing 10% (w/v) 
acrylamide is shown. Lane 1, cicap:rost (10 /.tM). Lane 2, iloprost (10 
/zM). Lanes 3 and 5, water added instead of stimulus (control). Lane 4, 
thrombin (1 U/ml). Lane 6, sulprostone (10 /.tM). Lane 7, PGE 2 (10 
/xM). Numbers on the left indicate raolecular masses ofmarker proteins 
(kDa). DF, dye front. 
under the experimental conditions employed. In order to 
answer the question whether PGs activate G~, we pro- 
longed the incubation time with [ tx-32p]GTP azidoanilide 
from 15 min to 30 min and overexposed the filters on 
X-ray films. Under these conditions, no stimulation by 
PGs with respect o labelling of 40 and 41 kDa proteins 
was detectable any more (Fig. 3, Panel B). However, only 
under both these conditions, enhanced incorporation of 
GTP azidoanilide could be detected into membrane pro- 
teins of 43 kDa after incubation of membranes with PGE 2, 
iloprost and cicaprost. In contrast, thrombin and sulpros- 
tone were without effect. This 43 kDa protein is likely to 
represent the immunological identified 43 kDa protein a 
subunit of G~. 
The G proteins G12/13- , Gq/ l l -  and G z are quite similar 
with respect o their very slow rate of guanine nucleotide 
exchange and intrinsic GTPase activity [23,34,35] and 
reduction of photolabelling of their ot subunits by GDP 
[23,34]. As we used 10/zM GDP in our assays, it is rather 
unlikely that the photolabelled 41 and 43 kDa membrane 
proteins are a subunits of these G proteins. 
Neither PGD 2 nor PGF2~ stimulated high-affinity GT- 
Pase, CTX-catalysed ADP-ribosylation or GTP azi- 
doanilide-labelling in HEL membranes, and this corre- 
sponds with their inability to increase [Ca 2÷ ]i in HEL cells 
[24]. 
4. Discussion 
shown). The as-peptide antiserum, AS 348, reacted with a 
faint protein band of 43 kDa (Fig. 1, lane 4), and recogni- 
tion of this 43 kDa protein was blocked by addition of the 
peptide, against which the a~-.peptide antiserum was raised 
(Fig. 1, lane 5). These data show that dae main CTX 
substrates with apparant molecular masses of 40, 41 and 
43 kDa comigrate with the a subunits of Gi2 , Gi3 and G s, 
respectively. 
We studied the effects of agonists on the CTX-catalysed 
ADP-ribosylation and photolabelling with GTP azi- 
doanilide of membrane proteins. Thrombin, PGE 2 and 
sulprostone as well as cicaprost and iloprost stimulated 
CTX-catalysed ADP-ribosylation of 40//41 kDa membrane 
proteins, corresponding to the a subunits of G i (Fig. 2). 
No stimulation of CTX-catalysed ADP-ribosylation of 43 
kDa proteins was detectable. 
To confirm these data, we applied a second method and 
performed GTP azidoanilide--labelling of membrane pro- 
teins. In these experiments, we increased the resolution of 
SDS-PAGE by running membrane proteins in separating 
gels containing 8% (w/v)  ac~rylamide and 4.3 M urea. As 
was the case in CTX-catalysed ADP-ribosylation experi- 
ments, thrombin, E- and I-type PGs enhanced incorpora- 
tion of GTP azidoanilide into 40 and 41 kDa membrane 
proteins (Fig. 3, Panel A). No incorporation of the photore- 
active GTP analogue in 43 kDa proteins could be observed 
In HEL cells, PGE 2 and sulprostone increase [Ca 2+ ]i in 
a PTX-sensitive manner [24]. The stimulation of GTPase 
induced by sulprostone was almost completely inhibited by 
PTX, whereas the GTP hydrolysis stimulated by PGE z 
was only partially inhibited by PTX (see Table 1). As 
PGE 2 possesses agonistic activity at EP1, EP 2 and EP 3 
receptor subtypes, but sulprostone only at EP 1 and EP 3 
receptor subtypes [2,3] it can be concluded that the EP 1 
and EP 3 receptor subtypes couple to G i proteins, whereas 
the EP 2 receptor subtype couples to a PTX-insensitive G 
protein, possibly G s. From our results, we also cannot 
exclude the possibility that EP 2 receptors additionally in- 
teract with PTX-sensitive G proteins. The indirect evi- 
dence for differential interaction of PG receptor subtypes 
with distinct G protein subtypes was confirmed by PG- 
stimulated CTX-catalysed ADP-ribosylation and by recep- 
tor-dependent photolabelling of membrane proteins. Both 
PGE 2 and sulprostone stimulated CTX-catalysed ADP- 
ribosylation of, and incorporation of GTP azidoanilide 
into, membrane proteins comigrating with G i protein o~ 
subunits (see Figs. 2 and 3). Furthermore and in contrast to 
sulprostone, only PGE 2 stimulated incorporation of GTP 
azidoanilide into proteins comigrating with a subunits of 
G s proteins (see Fig. 3). These findings corroborate the 
suggestion that EP 2 receptors interact at least with Gs 
proteins. 
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The results of cloning studies support our findings. The 
human EP 1 receptor, cloned from HEL cells, as well as the 
mouse EP 1 receptor, when expressed in Xenopus oocytes 
or Chinese hamster ovary cells, respectively, are function- 
ally coupled to increases in [Ca 2+ ]i and inositol phosphate 
concentration [4,5]. The human and mouse EP 2 receptors, 
expressed in Xenopus oocytes or COS cells, respectively, 
are functionally coupled to increases in cyclic AMP con- 
centration, suggesting signal transduction by G s proteins 
[6,7]. Expressed in Chinese hamster ovary cells, the mouse 
EP 3 receptor splice variants EP3~, EPa0, EP3~ and the 
bovine isoforms, EP3A and EP3D , are linked to adenylyl 
cyclase in an inhibitory manner [11,12]. In addition, ex- 
pression of the EP3~ and EP3D receptor isoforms, as well 
as the EP3B and EPac isoforms, leads to stimulation of 
adenylyl cyclase [11,12]. After reconstitution with purified 
G protein c~ subunits, the EPac receptor stimulated G~, 
inhibited G O and was without effect on G i proteins [22]. In 
terms of nucleotide sequences, the human EP31 isoform 
corresponds to the EP3~, the EPau isoform to the EP3~ and 
EP3D isoforms whilst EPam is a new isoform with un- 
known signal transduction [14]. Taken together, the inabil- 
ity of sulprostone to stimulate photolabelling of G s protein 
ce subunits argued against he notion, firstly, that the EP3n 
receptor isoform is expressed in HEL membranes and, 
secondly, that this receptor contributed to the effects de- 
scribed above. This was confirmed by cloning and expres- 
sion of only one EP 3 receptor from HEL cells, which 
corresponds to the EP3I and EP3, ~ splice variants [15]. 
In HEL cells, iloprost and cicaprost increase [Ca 2+ ]i in 
a PTX-insensitive and cyclic AMP-independent manner 
[24]. Interestingly, the increase in GTPase activity in HEL 
membranes caused by both agonists was partially inhibited 
by PTX (see Table 1). Whereas the former finding sug- 
gests that iloprost and cicaprost-induced increases in 
[Ca2+] i are mediated by PTX-insensitive G proteins, the 
latter finding suggests that both agonists, in addition, lead 
to the activation of PTX-sensitive G proteins. In agreement 
therewith, both agonists stimulated CTX-catalysed ADP- 
ribosylation and photolabelling of G i and G s protein cr 
subunits (see Figs. 2 and 3). Iloprost is known to possess 
agonistic activity both at EP 1 and IP receptors. Taking into 
consideration that the EP 1 receptor activates only G i pro- 
teins but not Gs, the data obtained with iloprost strongly 
confirm the view that the IP receptor activates G s proteins. 
In contrast o iloprost, cicaprost is assumed to be a highly 
selective agonist at IP receptors without agonistic activity 
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Fig. 3. Effects of thrombin and E- and I-type PG on GTP azidoanilide-labelling of O protein ot subunits in HEL membranes. Labelling with [ a -32 P]GTP 
azidoanilide was performed as described inSection 2 in the presence orabsence of stimuli. The incubation time with [ or-32 P]GTP azidoanilide was 15 rain 
(Panel A) and 30 min (Panel B). The gel shown in Panel B was overexposed on X-ray film. Typical autoradiograms of SDS gels containing 4.3 M urea and 
8% (w/v) acrylamide are shown. Lane 1, cicaprost (10/zM). Lane 2, iloprost (10/zM). Lanes 3 and 5, water added instead of stimulus (control). Lane 4, 
thrombin (1 U/ml). Lane 6, sulprostone (10/zM). Lane 7, PGE 2 (10/.tM). Numbers on the left indicate molecular masses of marker proteins (kDa). DF: 
dye front. Autoradiographies are representative for five (Panel A) and three (Panel B) independent experiments. 
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Table 2 
Activation of G protein a subunits by PG receptor subtypes in HEL cells 
13 
Agonist PG receptor subtypes a Experimental findings 
EP 1 EP 2 EP 3 IP GTPase b CTX-ADPR ¢ 40/41 AA[GTP] d 40/41 43 kDa 
PGE 2 + + + - 
Su lpros tone  + - + - 
I l opros t  + - - + 
C icapros t  - - - + 
ot subun i ts  e: 
O~ i Jr- - -  q.. h- 
a s - -  + - + 
+/-  + + + 
- + + - 
+/-  + + + 
+/ -  + + + 
The effects of E- and I-type PGs on PG receptor subtypes, experimental findings from this study and the suggested activation of a subunits of G i and G s 
proteins are summarized. The possible activation of G proteins other than G i and G s was not subject of this study and, therefore, not included in this table. 
a PG receptor activation (+)  or no activation ( - )  by the mentioned agonists according to Refs. [2,3]. 
b GTPase: inhibition ( - ) or partial inhibition ( + / - ) of PG-stimulated high-affinity GTPase by PTX according to Table 1. 
c CTX-ADPR: stimulated CTX-cata]ysed ADP-ribosylation (+)  of 40/41 kDa membrane proteins according to Fig. 2. 
d AA[GTP]: stimulation ( + ) or no stimulation ( - ) of incorporation of GTP azidoanilide into 40, 41 or 43 kDa membrane proteins according to Fig. 3A 
and B. 
e Suggested activation of a subunit,; of G i and G s proteins. 
activates both G i and G s proteins. Several explanations 
have to be discussed for our findings. Firstly, in HEL 
membranes, cicaprost binds, like iloprost, to EP and IP 
receptors. Secondly, cicapro,;t activates an at present un- 
known additional (IP) receptor subtype, which activates Gi 
proteins and, thirdly, cicaprost binds to IP receptors which 
may activate G i and Gs proteins. In addition, the PTX-in- 
sensitive and cyclic AMP-independent increase in [Ca 2+ ]i 
induced by both iloprost and cicaprost [24] suggests that a 
common receptor activated by these two agonists is cou- 
pled to another PTX-insen,;itive G protein a subunit, 
possibly a member of the Gq family. Interestingly, expres- 
sion of the mouse IP receptor in Chinese hamster ovary 
cells and human IP receptor in Xenopus oocytes and 
stimulation with iloprost leads to increases in cAMP and 
inositol phosphate concentration [16,17]. The latter effect 
was insensitive to PTX pretrcatment. These findings are in 
accordance with our results lhowing that the IP receptor in 
HEL cells is linked to multiple signaling pathways. 
Binding studies show high-affinity binding of 
[3H]iloprost in HEL membranes [37]. The EP 1- and a 
homologoue of the EP3I re, ceptor isoform were cloned 
from HEL cells [5,15], but it is not yet known whether 
HEL cells possess all EP receptor subtypes. Nevertheless, 
HEL cells are an interesting model to study the concert of 
EP- and IP receptor-mediated activation of Gi-type and Gs 
proteins in its natural environment because transfection 
studies have showed a reduced specificity of overex- 
pressed receptors for G proteins [38]. Our results may help 
to explain certain experimental findings reported in litera- 
ture, e.g., biphasic effects of PGE 2 in human platelets and 
myometrium [39,40] or the differential effects of iloprost 
in mast cells, which are consistent with the activation of 
Gs, G i and of an as yet unidentified PTX-insensitive G 
protein [41]. 
In conclusion, we have shown here that in HEL cells 
E-type PG differentially activate G i and G~ proteins by 
EP1/EP 3 and EP 2 receptors, respectively, and that the IP 
receptor is coupled to at least two G proteins, i.e., G s and 
Gi-type G proteins. A concise and simplified presentation 
of this study is given in Table 2. 
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